I expect this will be a slow build like with the breast cancer preclinical results. Science like this is not so easy to understand (I try my best), but many people need to run announcements like this past people they know who can understand the significance.
Ovarian cancer has always had great potential for RAC (that is why it was Path 5 in the 5-Path strategy) and now it has even more significance. The one thing we are not lacking at RAC is great opportunities!
Ann: Positive Early Preclinical Ovarian Cancer Results, page-37
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
-0.030(1.94%) |
Mkt cap ! $258.9M | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.57 | $1.50 | $75.34K | 49.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 49256 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |